Pierre Van Damme
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase 2 Study to Evaluate the Safety and Immunogenicity of Two Oral Poliovirus Vaccine Candidates (NCT04544787) | Pierre Van Damme | 2018-10-22 |
Track Pierre Van Damme automatically
Every clearance here is in the API, with alerts when new ones post.